Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -3.593.8626.35-4.601.38

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is -3.59 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-3.59
Mar20233.86
Mar202226.35
Mar2021-4.60
Mar20201.38

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35
Positive
Mar2021 -4.6
Negative
Mar2020 1.38 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹584.6 Cr 2.9% -12.1% -14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,228.0 Cr -2.4% -7.2% 27.2% Stock Analytics
DIVIS LABORATORIES ₹148,023.0 Cr 0% -9.2% 61.5% Stock Analytics
CIPLA ₹119,474.0 Cr 6% -3.8% 10.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,599.0 Cr 1.7% -11.4% 2.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,604.7 Cr 5.2% -2.1% 26.1% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

2.9%

-12.1%

-14.5%

SENSEX

1.7%

-1.3%

7.7%


You may also like the below Video Courses